1. GROUP REPOSIT STUDY (REPOSIT study group)
Information acquired: 2025
GROUP REPOSIT STUDY is an academic who published a paper in 2017 entitled Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characteristics (REPOSIT): study protocol of a phase II, open-label, multicenter study.